NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

March 3, 2015

Primary Completion Date

May 22, 2018

Study Completion Date

September 20, 2020

Conditions
Adult Soft Tissue Sarcoma
Interventions
DEVICE

NBTXR3

One intratumor implantation by injection

DEVICE

Radiation therapy

5 weeks/50 Gy (5 x 2 Gy by week)

Trial Locations (42)

Unknown

Capital Region Cancer Service, Canberra Hospital, Canberra

Chris O'Brien Lifehouse, Sydney

Jules Bordet Institute, Brussels

Ghent University Hospital, Ghent

Centre Rene Gauducheau, Nantes

Institut Bergonie, Bordeaux

Centre Leon Berard, Lyon

Institut Paoli Calmettes, Marseille

Centre Regional de Lutte Contre Le Cancer Paul Lamarque, Montpellier

Centre Antoine Lacassagne, Nice

Institut Curie, Paris

Institut Claudius Regaud - Oncopole, Toulouse

Institut Gustave Roussy, Villejuif

Klinikum Mannheim, Mannheim

Klinikum Nürnberg, Nuremberg

Princes of Wales Hospital, Shatin

Medical Centre, Hungarian Defence Forces, Budapest

National Institute of Oncology, Budapest

University Pècs, Pécs

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Institute of Oncology Veneto IOV, Padua

Instituto Nazionale Tumori Regina Elena, Rome

Oslo University Hospital, Oslo

Perpetual Succour Hospital Cebu, Cebu City

University of Santo Thomas, Manila

The Medical City, Pasig

St. Luke's Medical Center, Quezon City

Cancer Center Institute, Warsaw

Institutul Oncologic Bucuresti, Bucharest

Spitalului Universitar de Urgenta Militar Central, Bucharest

Amethyst-Cluj, Floreşti

County Hospital 'Dr Gavril Curteanu', Oradea

County Hospital, Targu Mures, Târgu Mureş

Municipal Emergency Hospital, Timișoara

Iatros International, Bloemfontein

The Oncology Centre, Durban

Gvi Outeniqua Oncology Unit, George

Wilgers Oncology Centre, Pretoria

Hospital Universitari Vall D'Hebron, Barcelona

Hospital Clinico Universitario San Carlos, Madrid

START MADRID, Hospital Fundacion Jimenez Diaz, Madrid

START MADRID, Hospital Universitario Madrid Norte Sanchinarro, Madrid

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

PharmaEngine

INDUSTRY

lead

Nanobiotix

INDUSTRY

NCT02379845 - NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall | Biotech Hunter | Biotech Hunter